355 related articles for article (PubMed ID: 19171332)
1. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
[TBL] [Abstract][Full Text] [Related]
2. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.
Seow KM; Juan CC; Hsu YP; Ho LT; Wang YY; Hwang JL
Hum Reprod; 2005 Jan; 20(1):117-21. PubMed ID: 15513972
[TBL] [Abstract][Full Text] [Related]
3. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
4. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
6. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.
Oktem M; Ozcimen EE; Uckuyu A; Esinler I; Pamuk B; Bayraktar N; Kulaksizoglu S; Zeyneloglu HB
Fertil Steril; 2009 Jun; 91(6):2545-50. PubMed ID: 18554599
[TBL] [Abstract][Full Text] [Related]
8. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
[TBL] [Abstract][Full Text] [Related]
9. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
[TBL] [Abstract][Full Text] [Related]
10. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
[TBL] [Abstract][Full Text] [Related]
11. Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.
Chan TF; Tsai YC; Chiu PR; Chen YL; Lee CH; Tsai EM
Fertil Steril; 2010 Feb; 93(3):869-73. PubMed ID: 19028383
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
13. Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.
Mashiach R; Amit A; Hasson J; Amzalzg S; Almog B; Ben-Yosef D; Lessing JB; Limor R; Azem F
Fertil Steril; 2010 May; 93(7):2299-302. PubMed ID: 19261276
[TBL] [Abstract][Full Text] [Related]
14. Relations between steroids and AMH: impact of basal and intrafollicular steroids to AMH ratios on oocyte yield and maturation rate in women with or without polycystic ovary undergoing in vitro fertilization.
Hossein G; Arabzadeh S; Hossein-Rashidi B; Hosseini MA
Gynecol Endocrinol; 2012 Jun; 28(6):413-7. PubMed ID: 21992510
[TBL] [Abstract][Full Text] [Related]
15. The insulin-resistant phenotype of polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L
Fertil Steril; 2010 Aug; 94(3):1052-8. PubMed ID: 19580964
[TBL] [Abstract][Full Text] [Related]
16. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome.
Erturk E; Kuru N; Savci V; Tuncel E; Ersoy C; Imamoglu S
Fertil Steril; 2004 Nov; 82(5):1364-8. PubMed ID: 15533361
[TBL] [Abstract][Full Text] [Related]
20. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]